Equels Thomas K bought AIM
May 6, 2024 · Form 4 insider transaction
Equels Thomas K bought 61,729 shares of AIM ImmunoTech Inc. at $0.41 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
61,729
Price
$0.41
Total value
$25.0K
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 6, 2024
Filing dateMay 7, 2024
Shares owned after778,184
OwnershipDirect
10b5-1 planNo
AmendedNo